A new international consortium to promote stem cell-based therapy for Huntington's disease
(University of Barcelona) The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) through cell transplantation studies on Huntington's Disease. The entity, made up of twenty-eight renowned researchers from ten countries, has been officially presented in a recent publication in the Journal of Huntington's Disease.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Huntington's Disease | International Medicine & Public Health | Stem Cell Therapy | Stem Cells | Study | Transplants